Mai Zhang

Global Development Lead, Senior Medical Director, Oncology Early Stage Development @ Pfizer

About

• Highly motivated clinical development professional, study-responsible physician and scientist, with hands-on clinical operational experience • More than 15 years of pharmaceutical industry experience in small molecule and biological drugs R&D • Therapeutic areas across oncology (solid tumor and hematological malignancies), immune disorders, and infectious diseases. • Strong analytical and problem-solving skills, and attention to details • Bilingual- English, Chinese (native)

Country

United States

City

San Diego

Industry

Pharmaceuticals

Skill

Lifesciences, Cell Culture, Drug Discovery, Assay Development, Cell Biology, Biomarkers, Molecular Biology, In Vivo, Biotechnology, Pharmaceutical Industry, ELISA, Cancer, Oncology, In Vitro, Immunology, Cell, Drug Development, Life Sciences, Flow Cytometry, Clinical Development

Experience

Global Development Lead, Senior Medical Director, Oncology Early Stage Development

Pfizer

2024-6 - Present · 2 yrs 4 mos

San Diego, California, United States

Medical Director, Oncology Early Development

Johnson & Johnson

2021-3 - 2024-5 · 3 yrs 3 mos

• Study responsible physician (SRP) for early development oncology trials • Responsible for medical monitoring, safety review and data interpretation • Authoring clinical sections of clinical documents (Protocol, Investigator Brochures, Informed Consent form, etc.) to support Health Authority and Ethics Committee submissions • Providing scientific input to the clinical strategic development plan

Associate Director, Clinical Program Scientist, Oncology Early Development

Johnson & Johnson

2020-9 - 2021-2 · 6 mos

• Study responsible scientist (SRS) for early development oncology trials • Working closely with internal cross-functional team, preparing Protocol, Clinical Study Reports and in Disease Area Stronghold and Compound Development Team activities, and interacting with investigators, coordinating clinical presentations at scientific meetings, and facilitating scientific publications

Associate Director, Clinical Program Scientist, Janssen Clinical Innovation

Johnson & Johnson

2017-9 - 2020-8 · 3 yrs

San Diego, California, United States

Scientific and operational lead of innovative early development programs (oncology [hematological malignancies] and immunology indications) including healthy volunteer and first-in-patient studies

Associate Director, Clinical Science

Mirati Therapeutics

2015-4 - 2017-9 · 2 yrs 6 mos

• Clinical study protocol development for phase I and phase II oncology trials (solid tumor), single agent and combo studies. • Clinical data review to assess safety and efficacy of the study drug. • Scientific and clinical literature review, scientific support for IND application, orphan drug designation request, phase Ib and phase II trials. • Trial management and CRO supervision

Senior Research Scientist

Siamab Therapeutics, Inc.

2010-7 - 2015-3 · 4 yrs 9 mos

Greater San Diego Area

Oncology drug discovery: development and optimization of a proprietary glycan microarray platform for antibody characterization; therapeutic antibody development (against tumor associated carbohydrate antigens, TACAs) for cancer diagnosis and treatment.

Research Scientist

Nexbio Inc

2008 - 2010 · 2 yrs

San Diego, CA

Biologic drug discovery for infectious diseases: anti-sepsis drug candidate selection and toxicity evaluation; pre-clinical support for clinical development of anti-flu drug in asthma setting.

Post-doc Fellow, Immunology department

Johnson & Johnson

2005 - 2008 · 3 yrs

Greater San Diego Area

Small molecule drug discovery for allergic and autoimmune diseases: evaluation of histamine H4 receptor (H4R) in cell-based functional assays and animal models for allergic asthma, atopic dermatitis, and rheumatoid arthritis; biomarker discovery and validation.